Literature DB >> 32963016

PEXIVAS: The End of Plasmapheresis for ANCA-Associated Vasculitis?

An S De Vriese1,2, Fernando C Fervenza3.   

Abstract

Entities:  

Keywords:  ANCA; PEXIVAS; Plasmapheresis; pulmonary hemorrhage; renal; severe

Mesh：

Year:  2020        PMID： 32963016      PMCID： PMC7863639          DOI： 10.2215/CJN.10550620

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

Review 1.  Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis.

Authors:  Michael Walsh; Fausta Catapano; Wladimir Szpirt; Kristian Thorlund; Annette Bruchfeld; Loic Guillevin; Marion Haubitz; Peter A Merkel; Chen Au Peh; Charles Pusey; David Jayne
Journal:  Am J Kidney Dis       Date:  2010-12-30       Impact factor: 8.860

2.  Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Annette N Bruchfeld; Lorraine Harper; Matthias Schaier; Michael C Venning; Patrick Hamilton; Volker Burst; Franziska Grundmann; Michel Jadoul; István Szombati; Vladimír Tesař; Mårten Segelmark; Antonia Potarca; Thomas J Schall; Pirow Bekker
Journal:  J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 10.121

3.  The Fate of Plasma Exchange and Glucocorticoid Dosing in ANCA-Associated Vasculitis After PEXIVAS.

Authors:  Frank B Cortazar; John L Niles
Journal:  Am J Kidney Dis       Date:  2020-04-08       Impact factor: 8.860

4.  Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.

Authors:  Marta Casal Moura; Maria V Irazabal; Alfonso Eirin; Ladan Zand; Sanjeev Sethi; Bijan J Borah; Jeffrey L Winters; James P Moriarty; Rodrigo Cartin-Ceba; Alvise Berti; Misbah Baqir; Gwen E Thompson; Ashima Makol; Kenneth J Warrington; Viengneesee Thao; Ulrich Specks; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2020-08-21       Impact factor: 10.121

5.  Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes.

Authors:  Rodrigo Cartin-Ceba; Luis Diaz-Caballero; Mazen O Al-Qadi; Stavros Tryfon; Fernando C Fervenza; Steven R Ytterberg; Ulrich Specks
Journal:  Arthritis Rheumatol       Date:  2016-06       Impact factor: 10.995

6.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

Authors:  Michael Walsh; Peter A Merkel; Chen-Au Peh; Wladimir M Szpirt; Xavier Puéchal; Shouichi Fujimoto; Carmel M Hawley; Nader Khalidi; Oliver Floßmann; Ron Wald; Louis P Girard; Adeera Levin; Gina Gregorini; Lorraine Harper; William F Clark; Christian Pagnoux; Ulrich Specks; Lucy Smyth; Vladimir Tesar; Toshiko Ito-Ihara; Janak Rashme de Zoysa; Wojciech Szczeklik; Luis Felipe Flores-Suárez; Simon Carette; Loïc Guillevin; Charles D Pusey; Alina L Casian; Biljana Brezina; Andrea Mazzetti; Carol A McAlear; Elizabeth Broadhurst; Donna Reidlinger; Samir Mehta; Natalie Ives; David R W Jayne
Journal:  N Engl J Med       Date:  2020-02-13       Impact factor: 91.245

7.  Effectiveness of plasmapheresis in ANCA clearance in patients with ANCA-associated vasculitides.

Authors:  Jacek Górka; Kamil Polok; Ilona Nowak; Anna Włudarczyk; Wojciech Sydor; Agnieszka Padjas; Jan Sznajd; Wojciech Szczeklik; Jacek Musiał
Journal:  Przegl Lek       Date:  2016

8.  Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.

Authors:  Michael Walsh; Alina Casian; Oliver Flossmann; Kerstin Westman; Peter Höglund; Charles Pusey; David R W Jayne
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

9.  Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.

Authors:  David R W Jayne; Gill Gaskin; Niels Rasmussen; Daniel Abramowicz; Franco Ferrario; Loic Guillevin; Eduardo Mirapeix; Caroline O S Savage; Renato A Sinico; Coen A Stegeman; Kerstin W Westman; Fokko J van der Woude; Robert A F de Lind van Wijngaarden; Charles D Pusey
Journal:  J Am Soc Nephrol       Date:  2007-06-20       Impact factor: 10.121

10.  With reasonable doubt: Plasma exchange in PEXIVAS.

Authors:  Bernd Hohenstein; Volker Schettler; Kirsten de Groot
Journal:  Ther Apher Dial       Date:  2020-04-28       Impact factor: 1.762
  10 in total
  2 in total

Review 1.  Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?

Authors:  Tamiko R Katsumoto; Kalin L Wilson; Vinay K Giri; Han Zhu; Shuchi Anand; Kavitha J Ramchandran; Beth A Martin; Muharrem Yunce; Srikanth Muppidi
Journal:  Immunother Adv       Date:  2022-05-27

Review 2.  Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management.

Authors:  Shangqing Ge; Xingyu Zhu; Qinyao Xu; Junyan Wang; Cheng An; Ying Hu; Fan Yang; Xinyi Wang; Yipin Yang; Shuwen Chen; Ruimin Jin; Haiyan Li; Xinchen Peng; Yue Liu; Junnan Xu; Minhui Zhu; Zongwen Shuai
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.